Clinical Trials Arena on MSN1d
Duchenne muscular dystrophy: Five trials to watch
Amid readouts from the Muscular Dystrophy Association’s annual meeting, the Clinical Trials Arena evaluates five DMD trials to keep an eye on in 2025.
The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs
Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward ...